Imagenetix Inc Quick Ratio (IAGX) starting from the first quarter 2015 to first quarter 2011, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Imagenetix Inc  (IAGX)

Imagenetix Inc's Quick Ratio

IAGX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Imagenetix Inc's Cash & cash equivalent grew by 45.72 % in the Q1 2015 sequentially, faster than Current Liabilities, this led to improvement in Imagenetix Inc's Quick Ratio to 0.09, Quick Ratio remained below Imagenetix Inc average.

Within Major Pharmaceutical Preparations industry 334 other companies have achieved higher Quick Ratio than Imagenetix Inc in first quarter 2015. While Quick Ratio total ranking in the first quarter 2015 has deteriorated compared to the prior quarter from 2402 to 4143.

Explain Quick Ratio?
How much Cash & cash equivalents IAGX´s has?
What are IAGX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IAGX Quick Ratio (Jun 30 2015)
Q1		 (Mar 31 2015)
Q3		 (Dec 31 2014)
Q2		 (Sep 30 2014)
Q3		 (Dec 31 2011)
Q2
Y / Y Current Liabilities Change -70.45 % -74.64 % -91.74 % -93.95 % -
Y / Y Cash & cash equivalent Change -55.69 % -81.64 % -75.9 % -35.95 % -
Quick Ratio MRQ 0.09 0.08 0.52 1.11 0.06
IAGX's Total Ranking # 4143 # 2402 # 4155 # #
Seq. Current Liabilities Change 18.28 % 185.14 % 28.71 % -93.19 % 1.53 %
Seq. Cash & cash equivalent Change 45.72 % -59.07 % -39.39 % 22.55 % -39.63 %



Quick Ratio first quarter 2015 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 335
Healthcare Sector # 674
Overall Market # 4143


Quick Ratio Statistics
High Average Low
1.11 0.45 0.06
(Sep 30 2014)   (Dec 31 2011)




Financial Statements
Imagenetix Inc's Current Liabilities $ 1 Millions Visit IAGX's Balance sheet
Imagenetix Inc's Cash & cash equivalent $ 0 Millions Visit IAGX's Balance sheet
Source of IAGX's Sales Visit IAGX's Sales by Geography


Cumulative Imagenetix Inc's Quick Ratio

IAGX's Quick Ratio for the trailling 12 Months

IAGX Quick Ratio

 (Jun 30 2015)
12 Months		 (Mar 31 2015)
12 Months		 (Dec 31 2014)
12 Months		 (Sep 30 2014)
12 Months		 (Dec 31 2011)
12 Months
Y / Y Current Liabilities TTM Growth -83.2 % -55.68 % -2.08 % 176.51 % -
Y / Y Cash & cash equivalent TTM Growth -64.51 % -50.8 % -7.42 % 263.93 % -
Quick Ratio TTM 0.24 0.14 0.13 0.14 0.11
Total Ranking TTM # 3738 # 0 # 0 # #
Seq. Current Liabilities TTM Growth -50.13 % -34.34 % -31.24 % -25.36 % 31.54 %
Seq. Cash & cash equivalent TTM Growth -17.02 % -29.24 % -33.59 % -8.99 % 15.03 %

Quick ratio ranking by company, industry and sector >> Back to IAGX Financial Strength Comparisons >> Go to Compare IAGX Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Imagenetix Inc's average Cash & cash equivalent, this led to increase in in Imagenetix Inc's Quick Ratio to 0.24, above IAGX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 168 other companies have achieved higher Quick Ratio than Imagenetix Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2015 from 0 to 3738.

Explain Quick Ratio?
How much Cash & cash equivalents IAGX´s has?
What are IAGX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 169
Healthcare Sector # 444
Within the Market # 3738


trailing twelve months Quick Ratio Statistics
High Average Low
0.15 0.15 0.15
(Jun 30 2015)  




Companies with similar Quick Ratio in the quarter ending Jun 30 2015, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2015 MRQ Cash & cash equivalentJun 30 2015 MRQ Current Liabilities
Igc Pharma Inc   0.25 $ 0.660  Millions$ 2.594  Millions
Lifecore Biomedical Inc   0.25 $ 14.127  Millions$ 56.159  Millions
Phibro Animal Health Corporation  0.24 $ 29.216  Millions$ 119.411  Millions
Bausch Health Companies Inc   0.22 $ 958.000  Millions$ 4,291.000  Millions
American Bio Medica Corporation  0.20 $ 0.433  Millions$ 2.163  Millions
Theriva Biologics inc   0.19 $ 4.757  Millions$ 25.498  Millions
Northwest Biotherapeutics Inc  0.17 $ 20.223  Millions$ 116.546  Millions
Allergan plc  0.16 $ 1,551.500  Millions$ 9,571.400  Millions
Cytodyn inc   0.16 $ 1.050  Millions$ 6.651  Millions
Cardax Inc   0.15 $ 0.673  Millions$ 4.602  Millions
Vaccinogen Inc  0.14 $ 0.965  Millions$ 7.133  Millions
Wellness Center Usa Inc  0.13 $ 0.128  Millions$ 0.959  Millions
Teva Pharmaceutical Industries Limited  0.13 $ 1,068.000  Millions$ 8,019.000  Millions
Nanomix Corp  0.12 $ 0.208  Millions$ 1.720  Millions
Mylan N v   0.11 $ 587.000  Millions$ 5,369.400  Millions
Cnbx Pharmaceuticals Inc   0.11 $ 0.022  Millions$ 0.203  Millions
Xenetic Biosciences Inc   0.11 $ 0.367  Millions$ 3.469  Millions
Insite Vision Inc  0.10 $ 1.755  Millions$ 17.431  Millions
International Stem Cell Corporation  0.10 $ 0.554  Millions$ 5.830  Millions
Generex Biotechnology Corp  0.09 $ 0.750  Millions$ 8.019  Millions
Imagenetix Inc  0.09 $ 0.092  Millions$ 0.996  Millions
Bioadaptives Inc   0.09 $ 0.012  Millions$ 0.133  Millions
Sunwin Stevia International Inc.  0.09 $ 0.522  Millions$ 6.001  Millions
Musclepharm Corporation  0.08 $ 4.170  Millions$ 54.243  Millions
Nascent Biotech Inc   0.07 $ 0.107  Millions$ 1.539  Millions
Abvc Biopharma Inc   0.06 $ 0.002  Millions$ 0.037  Millions
Whitehawk Therapeutics Inc   0.06 $ 0.010  Millions$ 0.178  Millions
Novaccess Global Inc  0.05 $ 0.033  Millions$ 0.645  Millions
Integrated Biopharma Inc  0.05 $ 0.572  Millions$ 11.865  Millions
Marker Therapeutics inc   0.04 $ 3.105  Millions$ 71.350  Millions

Date modified: 2026-08-29T17:14:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.